Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
10.1007/BF03160574 307 ShibataN.NagaiR.UchidaK.HoriuchiS.YamadaS.HiranoA.et al
With activist investors bemoaning returns on R&D and M&A investment and the loss of about $17bn in revenues looming from exclusivity expiries in 20252030, the company has been culling its pipeline and looking externally for assets
That's starting smart
Tools to stay on track , including meal logging, progress tracking, and practical resources
The trial is "double-blind," which means neither you nor your doctor knows whether you got the real drug or the placebo until the trial is over
US$ 23.33
US$ 28.60
US$ 22.75
US$ 27.83
US$ 25.67
US$ 22.27
